Related Experiment Videos

Tumor-dependent resistance of rat peritoneal macrophages to herpes simplex virus

Infection and Immunity
|February 1, 1983
PubMed

Insights

Solid tumors in rats impair macrophage antiviral activity against herpes simplex virus type 1. Bacterial adjuvants may restore this immune function in tumor-bearing hosts.

Area of Science:

  • Immunology
  • Virology
  • Oncology

Background:

  • Macrophages are crucial immune cells at infection sites, influencing host susceptibility to viral infections.
  • Macrophage antiviral activity is known to be affected by virus type and host age.

Purpose of the Study:

  • To investigate the impact of solid tumor development on the intrinsic antiviral activity of macrophages against herpes simplex virus type 1 (HSV-1).
  • To explore the potential of immunomodulation using bacterial adjuvants to restore macrophage antiviral function in tumor-bearing rats.

Main Methods:

  • Infectious center assays were performed.
  • Single-cycle growth curves of HSV-1 were analyzed in macrophages from normal and tumor-bearing rats.
  • The effects of bacterial adjuvants on peritoneal macrophages from tumor-bearing rats were assessed.

Main Results:

  • Macrophages from tumor-bearing rats exhibited depressed antiviral activity against HSV-1 compared to those from normal rats.
  • Immunomodulation with bacterial adjuvants demonstrated a positive effect on the antiviral activity of peritoneal macrophages in tumor-bearing rats.

Conclusions:

  • Solid tumor development significantly impairs macrophage intrinsic antiviral activity against HSV-1.
  • Bacterial adjuvants show potential for restoring macrophage antiviral functions in the context of cancer.

Related Concept Videos